Obio Technology (Shanghai) Corp., Ltd. (SHA:688238)
7.99
-0.08 (-0.99%)
Aug 21, 2025, 4:00 PM EDT
SHA:688238 Revenue
Obio Technology (Shanghai) Corp. had revenue of 67.01M CNY in the quarter ending June 30, 2025, with 25.28% growth. This brings the company's revenue in the last twelve months to 254.94M, up 8.90% year-over-year. In the year 2024, Obio Technology (Shanghai) Corp. had annual revenue of 248.15M with 21.16% growth.
Revenue (ttm)
254.94M
Revenue Growth
+8.90%
P/S Ratio
20.01
Revenue / Employee
368.41K
Employees
692
Market Cap
5.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 248.15M | 43.34M | 21.16% |
Dec 31, 2023 | 204.81M | -86.50M | -29.69% |
Dec 31, 2022 | 291.30M | 36.36M | 14.26% |
Dec 31, 2021 | 254.95M | 112.18M | 78.57% |
Dec 31, 2020 | 142.77M | 79.85M | 126.93% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 41.48B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |